Joint Identification of Efficacy and Safety Bounds in Binary Endpoint Studies

Identifying a therapeutic dose requires simultaneous consideration of efficacy and toxicity while controlling erroneous statistical conclusions across multiple dose levels. This study develops a joint confidence-based framework for identifying the minimum effective dose (MinED) and maximum safe dose (MaxSD) in trials with binary endpoints. The proposed approach integrates simultaneous confidence bounds, stepwise testing and the partitioning principle to characterise dose boundaries while addressing multiplicity. The theoretical framework establishes strong familywise error rate (FWER) control when the underlying joint confidence region achieves its required simultaneous coverage. A simultaneously adjusted Farrington–Manning score-based implementation was evaluated through a clinical illustration and simulation studies involving varying sample sizes, treatment effects and efficacy–toxicity dependence structures. The clinical illustration identified 100 mg as the only investigated dose satisfying both prespecified efficacy and safety criteria. Simulation results demonstrated favourable empirical FWER control, simultaneous coverage close to the nominal level and greater dose-identification power than a conservative exact-binomial benchmark, particularly with increasing sample sizes and treatment effects. These findings demonstrate the potential of simultaneous confidence-based inference for therapeutic-window identification, while highlighting the need for further finite-sample validation of the approximate score-based implementation.

Authors

Institutions

Publication Details

Journal
AppliedMath
Published
2026-11-19
DOI
https://doi.org/10.3390/appliedmath6110200
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Joint Identification of Efficacy and Safety Bounds in Binary Endpoint Studies

Saralees Nadarajah, John Ayuekanbey Awaab, Jakperik Dioggban, Emmanuel Dodzi Kpeglo et al.
AppliedMath
Statistical Methods in Clinical Trials
article

Joint Identification of Efficacy and Safety Bounds in Binary Endpoint Studies

Saralees Nadarajah, John Ayuekanbey Awaab, Jakperik Dioggban, Emmanuel Dodzi Kpeglo, Michael Jackson Adjabui
article en

Abstract

Identifying a therapeutic dose requires simultaneous consideration of efficacy and toxicity while controlling erroneous statistical conclusions across multiple dose levels. This study develops a joint confidence-based framework for identifying the minimum effective dose (MinED) and maximum safe dose (MaxSD) in trials with binary endpoints. The proposed approach integrates simultaneous confidence bounds, stepwise testing and the partitioning principle to characterise dose boundaries while addressing multiplicity. The theoretical framework establishes strong familywise error rate (FWER) control when the underlying joint confidence region achieves its required simultaneous coverage. A simultaneously adjusted Farrington–Manning score-based implementation was evaluated through a clinical illustration and simulation studies involving varying sample sizes, treatment effects and efficacy–toxicity dependence structures. The clinical illustration identified 100 mg as the only investigated dose satisfying both prespecified efficacy and safety criteria. Simulation results demonstrated favourable empirical FWER control, simultaneous coverage close to the nominal level and greater dose-identification power than a conservative exact-binomial benchmark, particularly with increasing sample sizes and treatment effects. These findings demonstrate the potential of simultaneous confidence-based inference for therapeutic-window identification, while highlighting the need for further finite-sample validation of the approximate score-based implementation.

AppliedMathVol. 6(11)
Kumasi Technical University (GH), University of Manchester (GB), Navrongo Health Research Centre (GH), C.K. Tedam University of Technology and Applied Sciences (GH), University of Professional Studies (GH)
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon